Ozempic, Wegovy Linked To Potential Vision Loss
MONDAY, Feb. 24, 2025 (HealthDay News) — People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition that affects the optic nerve, a new study says. Patients on semaglutide (Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anteriorContinue Reading